Literature DB >> 11676820

Pathogenesis of the permeability barrier abnormality in epidermolytic hyperkeratosis.

M Schmuth1, G Yosipovitch, M L Williams, F Weber, H Hintner, S Ortiz-Urda, K Rappersberger, D Crumrine, K R Feingold, P M Elias.   

Abstract

Epidermolytic hyperkeratosis is a dominantly inherited ichthyosis, frequently associated with mutations in keratin 1 or 10 that result in disruption of the keratin filament cytoskeleton leading to keratinocyte fragility. In addition to blistering and a severe disorder of cornification, patients typically display an abnormality in permeability barrier function. The nature and pathogenesis of the barrier abnormality in epidermolytic hyperkeratosis are unknown, however. We assessed here, first, baseline transepidermal water loss and barrier recovery kinetics in patients with epidermolytic hyperkeratosis. Whereas baseline transepidermal water loss rates were elevated by approximately 3-fold, recovery rates were faster in epidermolytic hyperkeratosis than in age-matched controls. Electron microscopy showed no defect in either the cornified envelope or the adjacent cornified-bound lipid envelope, i.e., a corneocyte scaffold abnormality does not explain the barrier abnormality. Using the water-soluble tracer, colloidal lanthanum, there was no evidence of tracer accumulation in corneocytes, despite the fragility of nucleated keratinocytes. Instead, tracer, which was excluded in normal skin, moved through the extracellular stratum corneum domains. Increasing intercellular permeability correlated with decreased quantities and defective organization of extracellular lamellar bilayers. The decreased lamellar material, in turn, could be attributed to incompletely secreted lamellar bodies within granular cells, demonstrable not only by several morphologic findings, but also by decreased delivery of a lamellar body content marker, acid lipase, to the stratum corneum interstices. Yet, after acute barrier disruption a rapid release of preformed lamellar body contents was observed together with increased organelle contents in the extracellular spaces, accounting for the accelerated recovery kinetics in epidermolytic hyperkeratosis. Accelerated recovery, in turn, correlated with a restoration in calcium in outer stratum granulosum cells in epidermolytic hyperkeratosis after barrier disruption. Thus, the baseline permeability barrier abnormality in epidermolytic hyperkeratosis can be attributed to abnormal lamellar body secretion, rather than to corneocyte fragility or an abnormal cornified envelope/cornified-bound lipid envelope scaffold, a defect that can be overcome by external applications of stimuli for barrier repair.

Entities:  

Mesh:

Year:  2001        PMID: 11676820     DOI: 10.1046/j.0022-202x.2001.01471.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  23 in total

Review 1.  Inherited ichthyoses/generalized Mendelian disorders of cornification.

Authors:  Matthias Schmuth; Verena Martinz; Andreas R Janecke; Christine Fauth; Anna Schossig; Johannes Zschocke; Robert Gruber
Journal:  Eur J Hum Genet       Date:  2012-06-27       Impact factor: 4.246

Review 2.  Ichthyosis update: towards a function-driven model of pathogenesis of the disorders of cornification and the role of corneocyte proteins in these disorders.

Authors:  Matthias Schmuth; Robert Gruber; Peter M Elias; Mary L Williams
Journal:  Adv Dermatol       Date:  2007

3.  Sebaceous gland, hair shaft, and epidermal barrier abnormalities in keratosis pilaris with and without filaggrin deficiency.

Authors:  Robert Gruber; Jeffrey L Sugarman; Debra Crumrine; Melanie Hupe; Theodora M Mauro; Elizabeth A Mauldin; Jacob P Thyssen; Johanna M Brandner; Hans-Christian Hennies; Matthias Schmuth; Peter M Elias
Journal:  Am J Pathol       Date:  2015-02-07       Impact factor: 4.307

4.  Cellular basis of secondary infections and impaired desquamation in certain inherited ichthyoses.

Authors:  Aegean Chan; Elena Godoy-Gijon; Almudena Nuno-Gonzalez; Debra Crumrine; Melanie Hupe; Eung-Ho Choi; Robert Gruber; Mary L Williams; Keith Choate; Philip H Fleckman; Peter M Elias
Journal:  JAMA Dermatol       Date:  2015-03       Impact factor: 10.282

5.  Lowered humidity produces human epidermal equivalents with enhanced barrier properties.

Authors:  Richard Sun; Anna Celli; Debra Crumrine; Melanie Hupe; Lillian C Adame; Sally D Pennypacker; Kyungho Park; Yoshikazu Uchida; Kenneth R Feingold; Peter M Elias; Dusko Ilic; Theodora M Mauro
Journal:  Tissue Eng Part C Methods       Date:  2015-01       Impact factor: 3.056

6.  Abnormal barrier function in the pathogenesis of ichthyosis: therapeutic implications for lipid metabolic disorders.

Authors:  Peter M Elias; Mary L Williams; Kenneth R Feingold
Journal:  Clin Dermatol       Date:  2012 May-Jun       Impact factor: 3.541

Review 7.  Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis.

Authors:  Peter M Elias; Joan S Wakefield
Journal:  J Allergy Clin Immunol       Date:  2014-08-15       Impact factor: 10.793

8.  Cellular and Metabolic Basis for the Ichthyotic Phenotype in NIPAL4 (Ichthyin)-Deficient Canines.

Authors:  Elizabeth A Mauldin; Debra Crumrine; Margret L Casal; Sekyoo Jeong; Lukáš Opálka; Katerina Vavrova; Yoshikazu Uchida; Kyungho Park; Brittany Craiglow; Keith A Choate; Kyong-Oh Shin; Yong-Moon Lee; Gary L Grove; Joan S Wakefield; Denis Khnykin; Peter M Elias
Journal:  Am J Pathol       Date:  2018-03-13       Impact factor: 4.307

9.  Tight junction properties change during epidermis development.

Authors:  Anna Celli; Yongjiao Zhai; Yan J Jiang; Debbie Crumrine; Peter M Elias; Kenneth R Feingold; Theodora M Mauro
Journal:  Exp Dermatol       Date:  2012-08-07       Impact factor: 3.960

10.  Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.

Authors:  William B Rizzo; Dana S'Aulis; M Anitia Jennings; Debra A Crumrine; Mary L Williams; Peter M Elias
Journal:  Arch Dermatol Res       Date:  2010-01-05       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.